Equity · Healthcare
SOPH
NASDAQSOPHiA GENETICS SA
The line runs $5.35 on 2 July through $8.21 on 18 September, on a scale from $5 to $9. Days the market did not trade hold the previous close, flat.
The chart above plots the price of SOPH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $5.35 on 2 July 2026 through $8.21 on 18 September 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Sep 18, 2026
SOPH insider trades
Showing the 12 most recent of 41 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
SOPH reported financials
SOPH reported revenue from contracts with customers of $77.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$79.0M.
Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025
SOPH institutional holders
4 of the 45 institutional funds we track reported a SOPH position for the quarter ended 30 Jun 2026 — a combined $2.0M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
SOPH fails-to-deliver
On 14 Sep 2026, 2,070 shares of SOPH failed to deliver (about $16K).
Source: SEC fails-to-deliver (CNS) data